Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Freeline Therapeutics stock
Own Freeline Therapeutics stock in just a few minutes.
Freeline Therapeutics Holdings plc is a biotechnology business based in the US. Freeline Therapeutics shares (FRLN) are listed on the NASDAQ and all prices are listed in US Dollars. Freeline Therapeutics employs 236 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Freeline Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FRLN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Freeline Therapeutics share price
Use our graph to track the performance of FRLN stocks over time.Freeline Therapeutics shares at a glance
Information last updated 2021-04-16.
| 52-week range | $11.85 - $21.69 |
|---|---|
| 50-day moving average | $13.67 |
| 200-day moving average | $16.03 |
| Wall St. target price | $25.67 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Buy Freeline Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Freeline Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Freeline Therapeutics financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -29.77% |
| Return on equity TTM | -57.55% |
| Profit margin | 0% |
| Book value | N/A |
| Market capitalisation | $445.2 million |
TTM: trailing 12 months
Shorting Freeline Therapeutics shares
There are currently 29,491 Freeline Therapeutics shares held short by investors – that's known as Freeline Therapeutics's "short interest". This figure is 8.8% down from 32,354 last month.
There are a few different ways that this level of interest in shorting Freeline Therapeutics shares can be evaluated.
Freeline Therapeutics's "short interest ratio" (SIR)
Freeline Therapeutics's "short interest ratio" (SIR) is the quantity of Freeline Therapeutics shares currently shorted divided by the average quantity of Freeline Therapeutics shares traded daily (recently around 11430.620155039). Freeline Therapeutics's SIR currently stands at 2.58. In other words for every 100,000 Freeline Therapeutics shares traded daily on the market, roughly 2580 shares are currently held short.
However Freeline Therapeutics's short interest can also be evaluated against the total number of Freeline Therapeutics shares, or, against the total number of tradable Freeline Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Freeline Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Freeline Therapeutics shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Freeline Therapeutics shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Freeline Therapeutics.
Find out more about how you can short Freeline Therapeutics stock.
Freeline Therapeutics share dividends
We're not expecting Freeline Therapeutics to pay a dividend over the next 12 months.
Freeline Therapeutics overview
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is FLT180a, a gene therapy product candidate that is in Phase 1/2 dose-finding clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in dose-escalating Phase 1/2 clinical trials for the treatment of Fabry disease; FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease; and FLT210, a liver-directed gene therapy product candidate for the treatment of hemophilia A. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. .
Frequently asked questions
More guides on Finder
-
T. Rowe Price review
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
-
How to buy ZTO Express Cayman stock
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
-
How to buy Zomedica stock
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
-
How to buy ZoomInfo Technologies stock
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
-
How to buy ZK International Group CoLtd stock
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
-
How to buy Zions Bancorporation National Association stock
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
-
How to buy Zentalis Pharmaceuticals stock
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong International stock
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
-
How to buy Zealand Pharma A/S stock
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong CTI stock
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
Ask an Expert